Cardiovascular adjustments to exercise are partially mediated by group III/IV (small to medium) 19 muscle afferents comprising the exercise pressor reflex (EPR). However, this reflex can be 20 inappropriately activated in disease states (e.g. peripheral vascular disease) leading to increased 21 risk of myocardial infarction. Here we investigate the voltage-dependent calcium (Ca V ) channels 22 expressed in small to medium muscle afferent neurons as a first step towards determining their 23 potential role in controlling the EPR. Using specific blockers and 5 mM Ba 2+ as the charge 24 carrier, we found the major calcium channel types to be Ca V 2.2 (N-type) > Ca V 2.1 (P/Q-type) > 25 -type). Surprisingly, the Ca V 2.3 channel (R-type) blocker SNX482 was without effect. 26
INTRODUCTION 41
The group I (Aα) and II (Aβ) muscle afferents provide sensory information needed to guide 42 motor activity (Houk 1974) . The group III (Aδ) and IV (C) afferents transmit muscle pain 43 signals and also mediate the exercise pressor reflex (ERP) (Kaufman and Hayes 2002) , which is 44 a critical neural mechanism that regulates the cardiovascular response to exercise (Kaufman and 45 Hayes 2002) . This reflex is clinically important because certain diseases such as peripheral 46 vascular disease and heart failure can produce muscle ischemia that drives EPR activity, which 47 can generate additional cardiac stress to increase the risk of myocardial infarction (Baccelli et al. 48 1999; Bakke et al. 2007; Smith et al. 2006 ). Here we investigate the Ca V channels expressed in 49 muscle afferent neurons as an initial step in understanding the role of these channels in 50 controlling excitability of neurons that mediate the EPR. 51 Ca V channels play a prominent role in neuronal excitability (Khosravani and Zamponi 2006) . At 52 synaptic terminals, they deliver the Ca 2+ needed to induce the release of excitatory and inhibitory 53 neurotransmitters (Lisman et al. 2007) . There are 10 genes that encode Ca V channels (Catterall 54 et al. 2005) . In dorsal root ganglia (DRG) neurons the evidence supports the expression of L-55 type (Ca V 1.2), P/Q-type (Ca V 2.1), N-type (Ca V 2.2), R-type (Ca V 2.3, also called E-type or α 1E ), 56
and T-type (CaV3.2) (Vanegas and Schaible 2000; Zamponi et al. 2009 ). The importance of 57 Ca V 2.2 channels in chronic pain has been highlighted by the success of the specific blocker 58 ziconotide or ω-conotoxin MVIIA) in the treatment of chronic pain in many patients 59 (Elmslie 2004; Molinski et al. 2009 ). This intrathecally delivered drug blocks transmission from 60 primary to secondary nociceptors by blocking presynaptic Ca V 2.2 channels (Motin and Adams 61 2008). While the effect of blocking presynaptic Ca V channels is to reduce CNS excitability, 62 blocking Ca V channels can also increase neuronal excitability through reduced activation of 63 4 closely associated Ca 2+ -activated potassium channels (Marrion and Tavalin 1998; Yu et al. 64 2010) . Indeed, blocking Ca V channels increases excitability of sensory neurons (Lirk et al. 65 2008) . Thus, it is important that we understand the Ca V channels expressed in muscle afferent 66 neurons, along with the modulation of these channels by molecular activators of the EPR. ATP 67 is one of these activators, which works by acting on P 2 X receptors (Cui et al. 2011; Hayes et al. 68 2008) . However, ATP can inhibit Ca V channels by activation of G-protein coupled P 2 Y 69 receptors (Filippov et al. 2003; Gerevich et al. 2004 ). Here we identify the Ca V channels that are 70 functionally expressed by muscle afferent neurons and show that ATP can inhibit the Ca V current 71 by reducing activity of Ca V 2.2 (N-type) channels. As with chronic pain, we show that Ca V 2.2 72 channels could be an important target for the treatment of symptoms resulting from excessive 73 EPR activity. 74 75 5
MATERIALS AND METHODS 76
Isolation of muscle afferent neurons: Adult male Sprague Dawley rats (wt 150-400 gms) were 77 obtained from Hill Top Laboratories (Scottdale, PA). All procedures were reviewed and 78 approved by the Institutional Animal Care and Use Committee and followed NIH guidelines. 79
The labeling and neuronal isolation followed previously described procedures (Ramachandra et 80 al. 2012) . Briefly, muscle afferent neurons were labeled by retrograde transport of the lipophilic 81 dye DiI (1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate) (100 μL of 1.5% 82 DiI in DMSO) that was injected into both left and right gastrocnemius muscles of anesthetized 83 rats (ketamine, xylazine and acepromazine). 4-5 days post injection, the rats were sacrificed with 84 CO 2 followed by decapitation. Neurons from the lumbar DRG L 4 and L 5 were isolated using an 85 enzyme mixture of trypsin, collagenase and DNAse and plated onto polylysine-coated glass 86 coverslips. The isolated neurons were maintained overnight at 37 °C in a 5% CO 2 incubator in 87
Minimal Essential Medium (MEM) with 10% fetal bovine serum (FBS) and 1% penicillin-88 streptomycin. 89
Expressed Ca V channels: Ca V 2.3 channels (α1, β2A and α2δ cDNA constructs, generous gifts 90 from Dr. Henry L. Puhl, NIH/NIAAA) were heterologously expressed in LN229 cells by 91 intranuclear microinjection at a ratio of 1:1:2. The cells were cultured in Dulbecco's Modified 92
Eagle Medium (DMEM), supplemented with 10% fetal bovine serum, 1% glutamine and 1% 93 penicillin-streptomycin. Following cDNA injection, the cells were incubated overnight and 94 electrophysiological recordings were performed the next day. 95
Solutions: Most DiI positive DRG neurons were initially recorded in an external solution 96 containing (in mM) 45 NaCl, 100 N-methyl d-glucosamine (NMG)•Cl, 4 MnCl 2 , 10 Na•HEPES, 97 6 10 glucose and 0.0003 Tetrodotoxin, with pH = 7.4 and osmolarity = 320 mOsm, which was 98 used to identify Na V 1.8 expressing muscle afferent neurons (Ramachandra et al. 2012 recorded in a solution containing (in mM): 140 NaCl, 5.4 KCl, 10 CaCl 2 , 1 MgCl 2 , 10 glucose 114 and 10 HEPES, pH 7.4 with NaOH. The internal solution was the same at that used for muscle 115 afferent neurons recorded in Ca 2+ . 116 Ion channel blockers were made up as stock solutions in either water or dimethyl sulfoxide 117 (DMSO) and diluted into the external solution to make the working concentration. All external 118 solutions contained the same DMSO concentration (max 0.03%) so that the only change was 119 presence or absence of the blocker. In experiments where Ca 2+ was the charge carrier, 0.1 mg/ml 7 cytochrome C was added to all external solutions to minimize potential binding of the peptide 121 toxins to the capillary columns used for drug delivery. Solutions were applied using a gravity fed 122 perfusion system with a solution exchange time of 2 seconds. 123
Measurement of ionic currents: DiI labeled DRG neurons were identified using a Nikon Diaphot 124 microscope with epifluorescence and voltage-clamped using the whole-cell configuration of the 125 patch clamp technique. Pipettes were pulled from glass capillaries (King Precision Glass, 126 Claremont, CA) on a Sutter P-97 puller (Sutter Instruments Co., Novato, CA). Currents were 127 recorded using either an Axopatch 200A or 200B amplifier (Molecular Devices, Sunnyvale, CA) 128 and digitized with an ITC-18 data acquisition interface (Instrutech Corporation, Port 129 Washington, NY). Experiments were controlled using S5 data acquisition software written by 130
Dr. Stephen Ikeda (NIH/NIAAA, Rockville, MD). Leak current was subtracted online using a -131 P/4 protocol. Recordings were carried out at room temperature and the holding potential was -80 132
mV. 133
Data analysis: Data were analyzed using IgorPro (WaveMetrics, Lake Oswego, OR) running on 134 a Macintosh computer. Cell diameter was calculated using the cell capacitance as previously 135 described (Ramachandra et al. 2012) . Group data were calculated as mean ± standard deviation 136 (SD) throughout the paper. Student's T-test (unpaired, two-tailed) was calculated to determine 137 significant differences (p < 0.05). 138
Immunocytochemistry: Neurons were fixed with 4% formaldehyde and permeabilized with 2% 139 Tween 20 as previously described (Ramachandra et al. 2012) . Neurons were labeled with 140 primary antibodies for both Na V 1.8 (mouse, Abcam, Cambridge, MA) and Ca V 2.3 (rabbit, 141
Alomone Labs, Jerusalem, Israel) (1:500) and visualized using secondary antibodies Alexa Fluor 142 488 IgG goat anti-rabbit and Alexa Fluor 635 IgG goat anti-mouse (Invitrogen, Carlsbad, CA). 143 8 Images were captured using a Nikon ECLIPSE 80i epifluorescence microscope and neurons 144 measured using ImageJ (rsbweb.nih.gov/ij/index.html). Cell size was calculated and positive 145 fluorescent labeling was determined as described previously (Ramachandra et al. 2012). 146 Chemicals: DiI, MEM, DMEM, FBS, penicillin/streptomycin were obtained from Invitrogen. 147 TTX citrate, nifedipine and SNX482 were obtained from Ascent Scientific (Princeton, NJ). ω-148 conotoxin GVIA (GVIA) and ω-agatoxin IVa (AgaIVa) were obtained from Bachem America 149 (King of Prussia, PA). All other chemicals were from Sigma (St. Louis, MO). 150 151 9
RESULTS 152
We were interested in determining the Ca V channels that are functionally expressed in muscle 153 afferent neurons. Consistent with previous work, we used pharmacology to determine the 154 percentage of total Ca V current generated by each channel type. Ca V 2.2 (N-type) was 155 determined from block by 10 µM GVIA, Ca V 2.1 (P/Q-type) from block by 0.2 µM AgaIVa, 156 Ca V 1.2 from block by 3 µM nifedipine (Nif) and Ca V 2.3 (R-type) from block by 0.3 µM 157 SNX482 (SNX) (Fuchs et al. 2007; Huang et al. 1997; Ikeda and Matsumoto 2003; Lu et al. 158 2010; Ohnami et al. 2011) . Using our 5 mM Ba 2+ external solution, we found that the largest 159 block was produced by GVIA (47 ± 19%, n = 20) > AgaIVa (25 ± 14%, n = 16) > Nif (13 ± 160 14%, n = 16) ( Fig. 1 ). The block produced by each of these three drugs was significant (p < 161 0.05). However, SNX produced no significant block (-7 ± 11%, n = 6). This was surprising since 162 previous work had shown SNX-sensitive currents in DRG neurons (Fang et al. 2007; Fuchs et al. 163 2007) . Perhaps muscle afferent neurons fail to express Ca V 2.3 channels. However, 22 ± 16% (p 164 < 0.05, n = 11) of the total Ca V current was resistant to all blockers (Resistant current). As 165 expected, only block by GVIA was irreversible (Boland et al. 1994; Liang and Elmslie 2002). 166 Previous work has shown differences in the percentage Ca V current blocked by various specific 167 blockers in small vs. medium or large DRG neurons (Fuchs et al. 2007; Scroggs and Fox 1992) . 168
Thus, it appears that expression of Ca V channel types can vary across classes of DRG neurons. 169 Unmyelinated C-type and thinly myelinated Aδ-type cutaneous afferents have cell body 170 diameters < 35 µm, with C-fibers having diameters < 23 µm (Djouhri et al. 2003) . However, 171 muscle afferents were found to have larger soma diameters relative to cutaneous afferents (Hu 172 and McLachlan 2003; Ramachandra et al. 2012 ). Thus, we include muscle afferent neurons up 173 to 40 µm in the group III (Aδ), and define small group IV (C) afferent neurons as those with cell 10 diameters < 30 µm (Ramachandra et al. 2013; Ramachandra et al. 2012) . While the Ca V current 175 was significantly blocked by Nif, AgaIVa and GVIA (but not SNX) in both groups, we found no 176 differences in percentage block by any Ca V channel blocker between small and medium neurons 177 ( Fig. 1B) , which is consistent with previous findings from cutaneous afferents (Lu et al. 2010) . 178
In addition, the resistant current was not different between these two groups at 21 ± 12% (n = 7) 179 of total Ca V current in small neurons and 25 ± 24% (n = 4) in medium neurons. A more detailed 180 examination of the Ca V channel block data is shown using scatter plots (Fig. 1C -E), which shows 181 that there are no systematic differences among muscle afferent neurons ranging from 20 to 40 182 µm diameter. Thus, neurons in both the group III (Aδ) and group IV (C) size range most 183 prominently express Ca V 2.2 > Ca V 2.1 > Ca V 1.2 ( Fig. 1) . 184
The functional expression of Ca V 3 (T-type) channels in DRG neurons has been demonstrated 185 (Ikeda and Matsumoto 2003; Jagodic et al. 2008; Scroggs and Fox 1992) , but we failed to 186 observe evidence of Ca V 3 currents in our recordings in Ba 2+ . Such currents are characterized by 187 low voltage activation (< -30 mV) and rapid inactivation (Scroggs and Fox 1992). To 188 quantitatively determine if Ca V 3 currents contributed to the total Ca V current, we calculated the 189 percentage inhibition over a range of voltages for each of the three blockers that produced 190 significant inhibitions. Ca V 3 currents would be revealed by the relatively smaller block at 191 hyperpolarized voltages where Ca V 3 channels dominate (Ikeda and Matsumoto 2003; Jagodic et 192 al. 2008; Scroggs and Fox 1992) . Using our standard holding potential (-80 mV) we found no 193 significant difference in the inhibition at -30 vs. +30 mV produced by any of our blockers (Fig.  194 2). It was not possible to do this analysis using more hyperpolarized voltages, since -30 mV was 195 the most hyperpolarized voltage to produce measureable current. Under these conditions it 196 11 appears that Ca V 3 channels do not significantly contribute to total Ca V current in muscle afferent 197 neurons. 198 Ca V 2.1 (P/Q) currents are typically blocked using sub-micromolar concentrations of AgaIVa 199 (Fuchs et al. 2007; Huang et al. 1997) , since Ca V 2.2 channels have been shown to be blocked by 200 1µM AgaIVa (Sidach and Mintz 2000) . However, Q-currents are a Ca V 2.1 isoform that is less 201 sensitive to AgaIVa block and is typically blocked using micromolar AgaIVa concentrations 202 (Randall and Tsien 1995; Sidach and Mintz 2000) . We wondered if a component of our resistant 203 current (22% of total Ca V current) was contributed by Q-channels. Therefore, we compared 204 block of muscle afferent Ca V current in 0.2 vs. 1 µM AgaIVa after block by GVIA to remove the 205 Ca V 2.2 component (Fig. 3) . In these neurons, GVIA blocked 50 ± 2% of current and 0.2 µM 206
AgaIVa blocked 26 ± 9% of current, but increasing AgaIVa to 1 µM blocked only an additional 207 4 ± 1% of current. Thus, a weakly AgaIVa-sensitive Ca V 2.1 channel type (e.g. Q-current) does 208 not substantially contribute to resistant current in muscle afferent neurons. 209
The absence of SNX-sensitive Ca V current was puzzling. We wondered if our use of Ba 2+ as the 210 charge carrier was the problem, since it was previously demonstrated that R-like Ca V current was 211 enhanced when Ca 2+ was the charge carrier (Boland et al. 1994; Liang and Elmslie 2001) . Using 212 the same blockers, we redid our study using a 10 mM Ca 2+ external solution. In addition, we 213 used a cumulative blocker application strategy to better gauge the resistant current (Fig. 4) . It 214 should be noted that under these recording conditions (HP -80 mV) we observed T-type currents, 215 but only in ~10% of muscle afferent neurons. The percentage block by Nif, GVIA and SNX was 216 statistically similar (p > 0.05) to that in Ba 2+ , and the resistant current was also similar between 217 Ca 2+ and Ba 2+ (p > 0.05). However, the block by AgaIVa was smaller in Ca 2+ (13 ± 2%) vs. Ba 2+ 218 (25 ± 14%). We do not understand the reasons for the smaller AgaIVa block in Ca 2+ , but it is 219 clear that Ca 2+ did not enhance SNX-sensitive current as we predicted. 220
As a positive control for SNX, we tested 0.3 µM SNX on Ca V 2.3 channels heterologously 221 expressed in LN229 cells. The recordings were done using a 10 mM Ca 2+ external solution and 222 SNX blocked 93 ± 8% (n = 3) of the expressed current. Thus, two possible explanations for the 223 absence of a SNX effect on muscle afferent neurons are that Ca V 2.3 channels are not expressed 224 by these neurons or the expressed Ca V 2.3 channels are insensitive to SNX. 225
Ca V 2.3 in muscle afferent neurons 226
SNX has been used in many experiments to define Ca V 2.3 current, but not all Ca V 2.3 channels 227 are sensitive to SNX (Tottene et al. 2000) . To determine if Ca V 2.3 channels were expressed in 228 muscle afferent neurons, we exposed isolated DRG neurons to a rabbit Ca V 2.3 antibody. For 229 consistency with our electrophysiological recordings, we also tested for the presence of Na V 1.8 230 using a specific mouse antibody. We found that all muscle afferent neurons were positively 231 labeled by the Ca V 2.3 antibody (Fig. 5A, B) , and all but one of these neurons were also labeled 232 by the Na V 1.8 antibody (Fig. 5C ). Most of the identified muscle afferent neurons had soma 233 diameters between 20-40 µm, which overlaps with the electrophysiological recordings. Thus, 234 muscle afferent neurons appear to express Ca V 2.3 channels. 235
We also wanted to test if these channels were functional, but our blocker (SNX) did not work. 236
One strategy was to use roscovitine, which is a Ca (Fig. 6 ). For these experiments, we tested the effect of 100 µM roscovitine after 241 blocking Ca V 2.1 and Ca V 2.2 with 0.2 µM AgaIVa and 10 µM GVIA, respectively. Figure 6A  242 shows the effect of roscovitine to inhibit step current and slow deactivation of total Ca V current 243 (before block of Ca V 2.1 and 2.2). After toxin application, the tail current is still reversibly 244 slowed by roscovitine ( Fig. 6B, C) . The roscovitine-induced inhibition was similar before and 245 after applications of the toxins with average reductions of 39 ± 15% and 52 ± 18% for control 246 and in toxins, respectively. The slowed deactivation shows that functional Ca V 2 channels 247 produce current in the presence of AgaIVa and GVIA. The similar inhibition before and after 248 toxin application suggests that roscovitine did not reverse toxin block to reveal Ca V 2.2 or 2.1 249 channels, which would have been caused either an increase in step current or a decrease in 250 inhibition. The most likely conclusion is that SNX resistant Ca V 2.3 channels comprise a large 251 fraction of the resistant Ca V current in small to medium muscle afferent neurons. 252
As a second test, we examined the Ni 2+ sensitive of the resistant current. It has been 253 demonstrated in major pelvic ganglion (MPG) neurons that SNX-resistant R-current is blocked 254 by Ni 2+ with an IC 50 (22 µM) similar to that of expressed Ca V 2.3 channels (21 µM) (Won et al. 255 2006) . Using Ba 2+ as the charge carrier, we tested the dose-response for Ni 2+ block of total Ca V 256 current and calculated an IC 50 = 246 µM (n = 3-4 neurons), which is expected for Ca V currents 257 dominated by Ca V 2.2 and 2.1 channels (Liang and Elmslie 2001; Zamponi et al. 1996) . 258 However, following application of 1 µM GVIA to block the dominant Ca V 2.2 current, the Ni 2+ 259 block IC 50 did not change with IC 50 = 319 µM (n = 7-8 neurons), which was against our 260 expectation of a decrease in IC 50 . It has been previously reported that the Ni 2+ sensitivity of 261 Ca V 2.3 current was ~300 µM when recorded in 10 mM Ba 2+ , but < 30 µM when recorded in 10 262 mM Ca 2+ (Zamponi et al. 1996) . In addition, the Ni 2+ -sensititive R-current of MPG neurons was 263 14 recorded in 10 mM Ca 2+ (Won et al. 2006) . Therefore, we reexamined the Ni 2+ block of Ca V 264 currents recorded in 10 mM Ca 2+ . We found that the Ni 2+ block of the resistant current 265 (nifedipine, GVIA and AgaIVa) recorded in Ca 2+ was much more potent than when recorded in 266 Ba 2+ with IC 50 = 4.4 µM (n = 2 to 5) and the maximum block = 64%. The potent Ni 2+ block 267 suggests that the majority of the resistant current (64%) was generated by the activity of Ca V 2.3 268 channels. 269 ATP modulates Ca V 2.2 channels 270 ATP helps to generate the EPR by activating P 2 X ionotropic receptors (Cui et al. 2011; Hayes et 271 al. 2008) , but ATP modulation of the reflex is also possible by activation of G protein-coupled 272 P 2 Y receptors. ATP has been shown to inhibit Ca V currents by activation of P 2 Y receptors 273 (Filippov et al. 2003; Gerevich et al. 2004 ), so we tested the effect on muscle afferent Ca V 274 currents (Fig. 7) . G protein-mediated inhibition of Ca V 2 currents is often found to be voltage-275 dependent in that the inhibition is temporarily reversed by brief, strong depolarization (Elmslie et 276 al. 1990; Ikeda 1991) . 10 µM ATP produced an average 32 ± 15% (n = 13) ( Fig. 7B) inhibition 277 of Ca V current that was reversed following strong depolarization (Fig. 7A ). In addition, there 278 was no clear difference in the percentage inhibition observed among neurons with diameters 279 ranging from 22-48 µm (Fig. 7B ). Previous reports have demonstrated Ca V 2.2 (N-type) to be a 280 major target of G protein-mediated inhibition (Elmslie et al. 1990; Gerevich et al. 2004; Ikeda 281 1991) , but other Ca V 2 channels can be modulated as well (Colecraft et al. 2000; Meza and 282 Adams 1998) . Thus, we determined the effect of GVIA on ATP modulation (Fig. 7D ). Prior to 283 GVIA application, ATP inhibited current (prepulse) by an average of 19 ± 8%, while the 284 inhibition was reduced to an average of 3 ± 4% following GVIA block of Ca V 2.2 channels in the 285 15 same 5 neurons. Ca V 2.2 channels are the primary Ca V channel target for ATP-induced inhibition 286 in muscle afferent neurons. 287
288

DISCUSSION 289
We have identified the Ca V channels that generate Ca V current in muscle afferent neurons along 290 with examining the modulation of that current by ATP. The results demonstrate that, regardless 291 of using external Ba 2+ or Ca 2+ , Ca V 2.2 channels dominate by generating 40-50% of the total Ca V 292 current. Ca V 2.1 channels generated between 13-25% of the current, while Ca V 1.2 channels 293 generated ~15% of the total current. The Ca V 2.3 channel blocker SNX had no effect on muscle 294 afferent Ca V current, while the portion of the current that was resistant to all blockers averaged 295 ~25% of the total current. Using roscovitine and Ni 2+ , we demonstrated that the majority of 296 resistant current is generated by CaV2.3, which shows that the current generated by this channel 297 type is roughly equal to that generated by Ca V 2.1. In the small to medium neurons recorded in 298 our study, there was no difference in Ca V channel expression between these two groups. ATP 299 inhibited Ca V current by activation of G protein-coupled receptors and that inhibition primarily 300 targeted Ca V 2.2 channels. Based on the neuronal size and the expression of Na V 1.8 by these 301 neurons (Ramachandra et al. 2012), we conclude that group IV (C) and group III (Aδ) neurons 302 primarily express Ca V 2.2 channels that are inhibited by extracellular ATP. 303
Ca V channels in sensory neurons 304
The percentage of Ca V channel types comprising the total current in our work matches well with 305 most studies on small and medium diameter sensory neurons with Ca V 2.2 > Ca V 2.1 = CaV2.3 > 306 Ca V 1.2 (Huang et al. 1997; Lu et al. 2010 ). However, Scroggs and Fox (1992) found a much 307 16 larger block by 2 µM nimodipine (53%) in small sensory neurons (20-27 µm) and a much 308 smaller block (7%) in medium sized neurons (33-38 µm) than we and others have observed. The 309 source of this difference is unclear, but it is possible that there is a population of DRG neurons in 310 which Ca V 1.2 channels dominate. 311
One important issue when using blockers to identify component channels is the specificity and 312 concentration of the chosen compounds. The blockers used in this study were the same as used 313 in many previous studies. GVIA is a highly specific blocker of Ca V 2.2 channels, but the 314 concentration we used was higher than some other studies (Fuchs et al. 2007; Huang et al. 1997; 315 Lu et al. 2010; Scroggs and Fox 1992) . Early studies of Ca V 2.3 showed this channel was 316 reversibly blocked by 5 µM GVIA when expressed in Xenopus oocytes (Zhang et al. 1993 ), but 317 we did not observe a reversible component to the GVIA block in our studies. In addition, GVIA 318 has been shown to be specific for Ca V 2.2 in neurons at concentrations up to 100 µM (Boland et 319 al. 1994; Elmslie 1997) . Finally, the percentage Ca V current blocked by GVIA in our study was 320 similar to that in studies using lower concentrations (Huang et al. 1997; Lu et al. 2010) . The 321 higher GVIA concentration in our study was used to ensure we could obtain data from multiple 322 blockers applied to the same neuron. GVIA is a very high affinity blocker, but the access to the 323 blocking site is highly sensitive to divalent cation concentration (Boland et al. 1994; Liang and 324 Elmslie 2002; Wagner et al. 1988 ). Thus, the blocking rate is much lower in higher divalent 325 cation concentrations (Boland et al. 1994; Liang and Elmslie 2002; Wagner et al. 1988 ) and also 326 much slower in Ca 2+ vs. Ba 2+ (Liang and Elmslie 2001) . Thus, our data collection when using 10 327 mM Ca 2+ was greatly enhanced by the fast block achieved using a higher GVIA concentration. 328
Unlike GVIA, there is evidence that Nif and AgaIVa loose selectivity at higher concentrations. 329
Nif has been shown to block non-L-type Ca V currents at 10 µM (Jones and Jacobs 1990), which 330 was one reason for our use of 3 µM. We were also able to achieve fast block of L-type channels 331 using this Nif concentration. AgaIVa is highly specific for Ca V 2.1 channels at submicromolar 332 concentrations, but Ca V 2.2 channels are blocked at concentrations ≥ 1 µM (Sidach and Mintz 333 2000) . Thus, like other studies, we utilized 0.2 µM AgaIVa for most of our experiments. 334
However, the Q-type variant of Ca V 2.1 is less sensitive to AgaIVa than the P-type variant 335 (Bourinet et al. 1999; Randall and Tsien 1995) . Thus, when determining if lower affinity Ca V 2.1 336 channel variants were expressed in muscle afferents, we preblocked Ca V 2.2 channels with GVIA, 337 which allowed us to show that only 4% of the total Ca V current could be attributed to Q-like 338 Ca V 2.1 channels. Since resistant current comprises ~25% of Ca V current, our results suggest that 339 Q-like Ca V 2.1 channels generate ~16% (4%/25%) of resistant current. 340
Current that is resistant to the classic Ca V channel blockers (e.g. GVIA, AgaIVa and Nif) was 341 originally termed R-current (Randall and Tsien 1995) . The identification of Ca V 2.3 (α1 E ) fit the 342 characteristics of R-current, and this channel type was called R-type (Zhang et al. 1993) . SNX 343 was identified as a blocker of Ca V 2.3 channels, but only a subpopulation of those channels was 344 sensitive to this blocker (Tottene et al. 2000) . We found that 22-27% of our Ca V current was 345 resistant to the classic Ca V channel blockers, but that current was also insensitive to SNX. Two 346 obvious possibilities were that Ca V 2.3 channels were not expressed in muscle afferent neurons, 347 or SNX insensitive variants were expressed in these neurons. We conclude that Ca V 2.3 channels 348 are expressed in muscle afferent neurons, but these channels are insensitive to SNX regardless of 349 with the majority (64%) of that current being generated by the activity of Ca V 2.3 channels (Won 358 et al. 2006) . The difference in Ni 2+ blocking affinity in Ca 2+ vs. Ba 2+ external solutions is also 359 consistent with the current being generated by Ca V 2.3 channels (Zamponi et al. 1996) . receptors could modulate the reflex. One potential mechanism for that modulation is via Ca V 366 channels. ATP has been shown to inhibit Ca V 2.2 channels by activation of P 2 Y receptors 367 (Filippov et al. 2003; Gerevich et al. 2004 ). Since the majority of neurons recorded for this study 368 had small to medium diameters and all expressed Na V 1.8, these neurons are likely group III and 369 IV neurons that participate in the EPR (Kaufman and Hayes 2002). Thus, we were interested in 370 the effect of ATP on Ca V current in our muscle afferent neurons. We found that ATP inhibited 371 Ca V current, and this inhibition primarily involved Ca V 2.2 channels. While we did not 372 specifically test the involvement of P 2 Y receptors, there is no doubt that the inhibition is 373 mediated via activation of G protein coupled receptors. G protein-mediated inhibition of Ca V 2 374 channels is characterized by rapid reversal following strong depolarization (Elmslie 1992; Ikeda 375 1991; Meza and Adams 1998), which was exhibited by the ATP-induced inhibition of Ca V 376
FIGURE LEGENDS 605
Figure 1
Ca V 2.2 channels generate the dominant Ca V current in muscle afferent neurons. 606 Ca V current in DiI labeled muscle afferent neurons was measured using 5 mM Ba 2+ Voltage independent block by Ca V channel blockers. A. Current-Voltage 616 relationships from a muscle afferent neuron in the presence of either 3 µM Nif, 0.2 µM AgaIVa, 617 or 10 µM GVIA. Ca V currents were measured in 5 mM Ba 2+ at the end of 25 ms voltage steps to 618 the indicated voltage. B. The mean inhibition (± SD) for each Ca V channel blocker is shown 619 over voltages ranging from -30 to 30 mV. The currents were measured as described for panel A. 620 There was no statistical difference between the block at -30 mV vs. that at 30 mV for each 621 blocker (n = 5 for each blocker). 622 623
Figure 3
Little or no Q current in muscle afferent neurons. Ca V current from muscle 624 afferent neurons was recorded in 5 mM Ba 2+ external solution. A. Example currents from a 625 muscle afferent neuron in control (Cntl), 10 µM GVIA, 0.2 µM AgaIVa, and 1 µM AgaIVa. B. 626 The mean (± SD) percentage block by GVIA and the two concentrations of AgaIVa tested on the 627
